Online citations, reference lists, and bibliographies.

Correction To: Does This Patient Have Pheochromocytoma? A Systematic Review Of Clinical Signs And Symptoms

A. Soltani, M. Pourian, Babak Mostafazadeh Davani
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
[This corrects the article DOI: 10.1186/s40200-016-0226-x.].
This paper references
10.1016/S0987-7053(99)80055-0
Harrison's principles of internal medicine
J. M. Guérit (1999)
10.1001/jama.1966.03110100062014
The neurologist's experience with pheochromocytoma. A review of 100 cases.
J. Thomas (1966)
10.1007/s12020-008-9108-4
Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma
E. W. Lai (2008)
10.1210/JC.2004-1398
Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma.
L. Amar (2005)
10.1097/00005792-199101000-00004
A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience.
P. Stein (1991)
A clinical scoring system for detection of patients with pheochromocytomas.
H. Black (1984)
A clinico - pathological study on pheochromocytoma at the University Hospital of the West Indies
C Charles (2009)
Pheochromocytomas in 72 patients : clinical and diagnostic features , treatment and long term results
IM Modlin (2001)
10.1002/9780470692196.CH4
Clinical Presentation of Pheochromocytoma
K. Pacak (2008)
Recent developments in pheochromocytoma diagnosis and imaging.
P. Plouin (1988)
10.1186/s40200-016-0226-x
Does this patient have Pheochromocytoma? a systematic review of clinical signs and symptoms
A. Soltani (2016)
10.1016/j.nucmedbio.2008.04.007
A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors.
I. Ilias (2008)
10.1186/s40200-016-0230-1
Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms
Mandana Pourian (2015)
10.1507/ENDOCRJ.48.151
Clinical differences between benign and malignant pheochromocytomas.
B. Glodny (2001)
10.1097/00000658-199906000-00001
Clinical experience over 48 years with pheochromocytoma.
R. Goldstein (1999)
10.1530/EJE.0.1500681
Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients.
J. Baguet (2004)
10.1002/ejs.6161681210
25 years experience of the surgical treatment of phaeochromocytoma.
U. Niemann (2002)
10.1001/archneur.1976.00500040065011
Symptoms of pheochromocytoma, with particular reference to headache, correlated with catecholamine production.
J. Lance (1976)
United States: Mc Graw Hill medical publication
Fauci
Prevalence of clinically unsuspected Pheochromocytoma
M G Sutton (1981)
Marston Linehan Pheochromocytoma : evaluation , diagnosis , and treatment
M McClellan (2005)
10.1634/theoncologist.2008-0043
Pheochromocytoma: current approaches and future directions.
J. Adler (2008)
[Screening for phaeochromocytoma : in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)].
P. Plouin (1981)
Pheochromocytoma--recent advances in diagnosis and treatment.
Neal L. Benowitz (1988)
10.1111/J.0954-6820.1988.TB15883.X
Long-term results in 64 patients operated upon for pheochromocytoma.
G. Stenström (1988)
10.1016/S0002-9610(00)00296-8
Adrenal pheochromocytoma remains a frequently overlooked diagnosis.
C. Lo (2000)
Diagnosis and treatment of pheochromocytoma in an academic hospital
R Yu (1997)
Pheochromocytoma: a twenty year experience at the University Hospital.
F. Aguiló (1991)
10.1080/10253890701395896
Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice
T. Zelinka (2007)
Tumor recurrence and
PF Plouin (1994)
Phaeochromocytoma in the Hong Kong Chinese population.
J. Y. Yau (2010)
10.1530/EJE.0.1410619
Pheochromocytoma in Italy: a multicentric retrospective study.
M. Mannelli (1999)
O’Higgins N. 47 years of phaeochromocytomas
T O’Halloran (2001)
10.1016/S0895-7061(99)00139-9
Changes in clinical features and long-term prognosis in patients with pheochromocytoma.
T. Noshiro (2000)
10.1016/j.amjmed.2008.08.021
Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007.
R. Yu (2009)
10.1007/s002689900454
Pheochromocytoma, a Rare Cause of Hypertension: Long-term Follow-up of 55 Surgically Treated Patients
G. Favia (1998)
10.1016/S0009-9120(00)00172-7
A five-year report on experience in the detection of pheochromocytoma.
F. C. Hernández (2000)
10.1530/EJE-09-0384
Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma.
Robert Kopetschke (2009)
10.1097/CRD.0000000000000141
Cardiovascular Manifestations of Pheochromocytoma
Yu Gu (2017)
Pheochromocytoma. Lancet. 2005;366:665–75
JW Lenders (2005)
10.1001/archinte.1993.00410020010002
The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
(1993)
10.1161/01.HYP.29.5.1133
Tumor recurrence and hypertension persistence after successful pheochromocytoma operation.
P. Plouin (1997)
10.1097/00008469-200410000-00008
Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 41 cases investigated in a single endocrine centre
A. Patócs (2004)
10.1016/S0025-7125(16)30088-8
Pheochromocytoma. Update on diagnosis, localization, and management.
S. Werbel (1995)
10.1007/s003450050102
Pheochromocytoma: evaluation, diagnosis, and treatment
M. Walther (1999)
10.1111/J.1365-2796.2005.01504.X
Long-term outcome of a large series of patients surgically treated for pheochromocytoma.
A. Khorram-Manesh (2005)
10.1055/s-0029-1237699
False positive test results for pheochromocytoma from 2000 to 2008.
R. Yu (2010)
10.1530/EJE-10-0114
Pheochromocytomas detected by biochemical screening in predisposed subjects are associated with lower prevalence of clinical and biochemical manifestations and smaller tumors than pheochromocytomas detected by signs and symptoms.
Nicolette van Duinen (2010)
Current approaches and future directions
Adler JT et al. Pheochromocytoma (2016)
10.1016/S0022-5347(17)53807-0
Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series.
M. G. Sutton (1981)
10.1097/HJH.0b013e32813aeb5a
Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients
J. Václavík (2007)
10.1007/BF00353738
“The” pheochromocytoma: A benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist?
C. Proye (1994)
10.1097/00000658-199011000-00010
Surgical management of pheochromocytoma with the use of metyrosine.
R. Perry (1990)
Pheochromocytoma: a 10-year experience in a tertiary care North Indian hospital.
N. Sharma (2001)
10.1093/qjmed/90.1.51
Phaeochromocytoma: a ten-year survey.
K. Loh (1997)
10.3126/KUMJ.V10I3.8020
Phaeochromocytoma in Nepal--a single centre experience.
P. Maskey (2012)
47 years of phaeochromocytomas.
T. O'Halloran (2001)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar